Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

DexCom Inc., consolidated cash flow statement

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net income (loss)
Depreciation and amortization
Share-based compensation
Collaborative research and development fee
Loss on extinguishment of debt
Non-cash interest expense
Non-cash collaborative research and development fee through issuance of common stock
Unrealized gain on equity investment
Realized (gain) loss on equity investment
Deferred income taxes, including benefit from valuation allowance release
Other non-cash income and expenses
Accounts receivable, net
Inventory
Prepaid and other assets
Operating lease right-of-use assets and liabilities, net
Accounts payable and accrued liabilities
Accrued payroll and related expenses
Deferred revenue and other liabilities
Changes in operating assets and liabilities
Adjustments to reconcile net income (loss) to cash provided by operating activities
Net cash provided by operating activities
Purchase of marketable securities
Proceeds from sale and maturity of marketable securities
Purchases of property and equipment
Acquisitions, net of cash acquired
Other investing activities
Net cash used in investing activities
Net proceeds from issuance of common stock
Purchases of treasury stock
Proceeds from issuance of convertible notes, net of issuance costs
Repurchase of convertible notes
Proceeds from sale of warrants
Purchase of convertible note hedge
Other financing activities
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. DexCom Inc. net cash provided by operating activities decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. DexCom Inc. net cash used in investing activities increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. DexCom Inc. net cash provided by (used in) financing activities decreased from 2020 to 2021 and from 2021 to 2022.